$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
How many years can I take Osimertinib
2025-10-19 11:44:20
Check Details
Is serpatinib effective against bone metastasis
2025-10-19 11:44:20
Check Details
How to deal with the side effects of platinib
2025-10-19 11:44:20
Check Details
What are the side effects of larotinib
2025-10-19 11:44:20
Check Details
Which generation of targeted drug is crizotinib?
2025-10-19 11:44:20
Check Details
How effective is entrectinib treatment
2025-10-19 11:44:20
Check Details
Adverse reactions of rubitidine
2025-10-19 11:44:20
Check Details
Is rubitidine effective in treating lung cancer
2025-10-19 11:44:20
Check Details
Does larotrectinib treat cancer regardless of cancer type?
2025-10-19 11:44:20
Check Details
Which one has more side effects, capmatinib or servotinib
2025-10-19 11:44:20
Check Details
What are the adverse reactions of adagrasib in the treatment of lung cancer
2025-10-19 11:44:20
Check Details
How many years can you take afatinib at most
2025-10-19 11:44:20
Check Details
1
2
...
4118
4119
4120
4121
4122
4123
4124
...
4155
4156
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
2
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
3
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
4
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
5
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage
6
Pemigatinib Efficacy: Significantly Improving Survival in FGFR2-Fusion Cholangiocarcinoma
7
Erlotinib: Targeting EGFR Mutations to Precisely Inhibit Non-Small Cell Lung Cancer Growth
8
Tofacitinib: The Role and Considerations of an Oral JAK Inhibitor in Autoimmune Disease Treatment
9
Tucatinib: Redefining the Treatment Landscape for HER2-Positive Cancers with High Selectivity
10
Complete Guide to Garsorasib Resistance Mechanisms and Follow-Up Treatments
11
Vemurafenib: An Oral Targeted Therapy for BRAF V600E-Mutant Melanoma
12
Vemurafenib: Precision Targeting of BRAF Mutation, Revolutionizing Melanoma Treatment